Market Wire - Medical and Healthcare

Syneron Medical Ltd.: Syneron Medical to Present at Collins Stewart Growth Conference - July 2, 2008

YOKNEAM, ISRAEL (MARKET WIRE) Syneron Medical Ltd. (NASDAQ: ELOS), an innovator in the development, marketing and sales of elos(TM) combined-energy medical aesthetic devices, announced today that Syneron will participate in the Collins Stewart Growth Conference on Tuesday, July 8, 2008 in New York. Founder and Chairman, Dr. Shimon Eckhouse, will present on behalf of Syneron at 10:00 a.m. ET.
http://www2.marketwire.com/mw/release_html_b1?release_id=412404&tsource=3

MediSolution Ltd.: Eastern Health Selects MediSolution's Virtuo HR Solution for Regional Deployment - July 2, 2008

MONTREAL, QUEBEC (MARKET WIRE) MediSolution Ltd. (TSX: MSH), today announced that Eastern Health, the largest integrated health organization in Newfoundland and Labrador, will expand the deployment of MediSolution's comprehensive Virtuo Human Resource (HR) solution throughout its organization. The contract which includes Virtuo HR's, Recruitment, Personnel and Training modules will be implemented over the next 12 months.
http://www2.marketwire.com/mw/release_html_b1?release_id=412723&tsource=3

MedaSorb Technologies Corporation: MedaSorb Technologies Corporation Raises $4.45 Million; Funds to Be Used for Current Sepsis Clinical Study and to P - July 2, 2008

MONMOUTH JUNCTION, NJ (MARKET WIRE) MedaSorb Technologies Corporation (OTCBB: MSBT) (FRANKFURT: HQE), a medical device company focused on the development of its platform technology for the removal of toxins from blood and physiologic fluids, announced today the closing of a $4.45 million private placement of its Series B 10% Cumulative Convertible Preferred Stock. The funding is targeted for its Sepsis Study currently underway in Germany. In addition, the funding will allow MedaSorb to...
http://www2.marketwire.com/mw/release_html_b1?release_id=412690&tsource=3

Reportlinker.com: Examine the World Feminine Hygiene Products Market - July 2, 2008

LONDON, UNITED KINGDOM (MARKET WIRE) Reportlinker.com announces that a new market research report related to the Feminine hygiene industry is available in its catalogue.
http://www2.marketwire.com/mw/release_html_b1?release_id=412578&tsource=3

Reportlinker.com: Key Challenges and Issues facing the World Immunoassay Instruments Market - July 2, 2008

LONDON, UNITED KINGDOM (MARKET WIRE) Reportlinker.com announces that a new market research report related to the Medical devices industry is available in its catalogue.
http://www2.marketwire.com/mw/release_html_b1?release_id=412576&tsource=3

Reportlinker.com: Focus on the World Condoms Market - July 2, 2008

Gaymar Industries: Gaymar Acquires Sunshine Manufacturing, Leading Producer of Specialty Gel Components - July 2, 2008

ORCHARD PARK, NY (MARKET WIRE) Gaymar Industries, the leading global provider of medical solutions for pressure ulcer and temperature management, announced today that the company has acquired the assets of Sunshine Manufacturing, LC, an innovative manufacturer of specialty gel components located in Alpine, Utah. Gaymar was Sunshine's largest customer. Terms of the sale between the two private parties were not disclosed.
http://www2.marketwire.com/mw/release_html_b1?release_id=412509&tsource=3

Galapagos NV: Galapagos creates new warrant plans - July 2, 2008

MECHELEN, BELGIUM (MARKET WIRE) Galapagos NV (Euronext: GLPG) announced today that its Board of Directors on 26 June 2008 has created and offered 250,065 warrants under a new warrant plan for Galapagos employees and consultants. Furthermore, the Extraordinary General Shareholders' Meeting (EGM) held on 26 June 2008 approved the offer of 57,500 warrants for the benefit of directors of the company.
http://www2.marketwire.com/mw/release_html_b1?release_id=412524&tsource=3

Sonomax Hearing Healthcare Inc.: Highlights From Sonomax's Annual General Meeting and June Monthly Update Conference Call - July 2, 2008

MONTREAL, QUEBEC (MARKET WIRE) Sonomax Hearing Healthcare Inc. (TSX VENTURE: SHH) is please to provide a summary of the highlights of the AGM held on June 26, 2008 and the Monthly Update Conference Call held on June 27, 2008.
http://www2.marketwire.com/mw/release_html_b1?release_id=412525&tsource=3

Kane Biotech Inc.: A New Study Shows DispersinB(TM) Helps Our Body's Immune Cells to Kill Bacteria - July 2, 2008

WINNIPEG, MANITOBA (MARKET WIRE) Kane Biotech Inc. (TSX VENTURE: KNE), a biotechnology company engaged in the development of products that prevent and remove microbial biofilms, is pleased to announce a research publication on its DispersinB(TM) technology. The manuscript appeared in the recent online edition of Microbial Pathogenesis (2008), doi: 101016j.micpath.2008.05.007.
http://www2.marketwire.com/mw/release_html_b1?release_id=412507&tsource=3